SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-05-097842
Filing Date
2005-05-06
Accepted
2005-05-05 19:10:58
Documents
7
Period of Report
2005-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR INVITROGEN CORPORATION d10q.htm 10-Q 516594
2 SHARE SALE AND PURCHASE AGREEMENT dex29.htm EX-2.9 263786
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 7943
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 7952
5 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3526
6 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3393
7 GRAPHIC g18243img001.jpg GRAPHIC 4908
  Complete submission text file 0001193125-05-097842.txt   811490
Mailing Address 1600 FARADAY AVE CARLSBAD CA 92008
Business Address 1600 FARADAY AVE CARLSBAD CA 92008 7606037200
INVITROGEN CORP (Filer) CIK: 0001073431 (see all company filings)

IRS No.: 330373077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25317 | Film No.: 05805126
SIC: 2836 Biological Products, (No Diagnostic Substances)